Underappreciated Statin-Induced Myopathic Weakness Causes Disability
Neurorehabil Neural Repair 19:259-263, Dobkin,B.H., 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
JAMA 293:2496-2500, Levin,L.I.,et al, 2005

High Titers of CA-125 May Be Associated weith Recurrent Ischemic Strokes in Patients with Cancer
Neurol 64:1944-1945, Jovin,T.G.,et al, 2005

Rabies Encephalomyelitis
Arch Neurol 62:873-882,855, Burton,E.C.,et al, 2005

Seizures Following Reduction in Phenytoin Level After Orally Administered Folic Acid
Neurol 64:1982, Steinweg,D.L.&Bentley,M.L., 2005

Dysphagia as the Sole Manisfestation of Myasthenia Gravis
JNNP 76:1297-1300, Llabrs,M.,et al, 2005

Hyperglycemic Hemianopia: A Reversible Complication of Non-Ketotic Hyperglycemia
Neurol 65:616-619, Lavin,P.J.M., 2005

Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005

Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005

Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Hyperhomocysteinemia, Low Folate and Vitamin B12 Concentrations, and Methylene Tetrahydrofolate Reductase Mutation in Cerebral Venous Thrombosis
Stroke 35:1790-1794, Cantu,C.,et al, 2004

Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004

The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004

Liver Injury Associated with the B-Interferons for MS
Neurol 62:628-631, Tremlett,H.L.,et al, 2004

Copper Deficiency Myelopathy
Arch Neurol 61:762-766, Kumar,N.,et al, 2004

An Unusual Cause of Psychosis
Lancet 363:1522, Singh,S.,et al, 2004

B- and T-cell Markers in Opsoclonus-Myoclonus Syndrome
Neurol 62:1526-1532,1466, Pranzatelli,M.R.,et al, 2004

Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004

Are MuSK Antibodies the Primary Cause of Myasthenic Symptoms?
Neurol 62:1945-1950,1920, Selcen,D.,et al, 2004

Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke 35:1903-1907, Leigh,R.,et al, 2004

Reversible Hyperintensity Lesion on Diffusion-Weighted MRI in Hypoglycemic Coma
Neurol 63:392-393, Aoki,T.,et al, 2004

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Unilateral Putaminal CT, MR, and Diffusion Abonromalities Secondary to Nonketotic Hyperglycemia in the Setting of Acute Neurologic Symptoms Mimicking Stroke
AJNR 25:975-976, Wintermark,M.,et al, 2004

West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004

Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004

Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004

Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004

Mitoxantrone Treatment of Multiple Sclerosis
Neurol 63(Suppl 6):S28-S32, Cohen,B.A. &Mikol,D.D., 2004

Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004

Amyloid Myopathy Presenting with Distal Atrophic Weakness
Muscle Nerve 29:605-609, Smestad, C.,et al, 2004

Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003

Investigation of Risk Factors in Children with Arterial Ischemic Stroke
Ann Neurol 53:167-173,149, Ganesan,V.,et al, 2003

Bilateral Striatal Necrosis Associated with Mycoplasma pneumoniae Infection
NEJM 348:720, van Vuiren,M. &Uhl,M., 2003

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003

Brain MR Imaging in Acute Hyperammonemic Encephalopathy Arising from Late-Onset Ornithine Transcarbamylase Deficiency
AJNR 24:390-393, Takanashi,J-i.,et al, 2003

POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003

West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Homocysteine and Risk of Recurrent Stroke
Stroke 34;1258-1261, Boysen,G.,et al, 2003

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis After a First Demyelinating Event
NEJM 349:139-145,107, Berger,T.,et al, 2003

Asking the Right Question
Lancet 361:1786, Schattner,A.,et al, 2003

Taenia solium Cysticercosis
Lancet 362:547-556, Garcia,H.H.,et al, 2003

Lupus and Zoster
Lancet 362:616, Douglas,K.M.J., 2003

Polymyositis and Dermatomyositis
Lancet 362:971-982, Dalakas,M.C.&Hohlfeld,R., 2003

Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003

Multifocal Varicella-Zoster Virus Vasculopathy Without Rash
Arch Neurol 60:1607-1609, Russman,A.N.,et al, 2003

Hyperhomocysteinemia as an Independent Risk Factor for Silent Brain Infarction
Neurol 61:1595-1599, Kim,N.K.,et al, 2003